Charles River Laboratories | CRL - Debitur Perdagangan





Debitur Perdagangan Perubahan Tanggal
Agilent USD 1.5B 23M 2026-03
Align Technology USD 1.13B 23.36M 2026-03
Bio-Rad Laboratories USD 460.6M 4.1M 2025-12
Bruker USD 542.7M 2.2M 2026-03
Cardinal Health USD 13.65B 14M 2026-03
Charles River Laboratories USD 700.25M 727.92M 2026-03
Cigna USD 26.61B 6.26B 2026-03
Concord Medical Services Hldg CNY 57.36M 40.75M 2025-06
CVS Health USD 40.99B 1.21B 2026-03
Danaher USD 4.76B 845M 2026-03
Dentsply International USD 622M 66M 2026-03
Elevance Health USD 22.79B 1.25B 2026-03
Humana USD 5.22B 1.95B 2026-03
Illumina USD 738M 116M 2026-03
Incyte USD 1.05B 27.09M 2026-03
Intrexon USD 1.02M 559K 2024-06
IQVIA Holdings USD 3.38B 52M 2026-03
Laboratory Of America USD 2.45B 189.8M 2026-03
Lakefront Biotherapeutics EUR 54.03M 145.72M 2026-03
Lonza CHF 1.78B 55M 2025-12
McKesson USD 27.99B 228M 2026-03
Merck EUR 4.81B 373M 2026-03
Mettler Toledo International USD 708.21M 70.04M 2026-03
Novartis USD 9.6B 2.69B 2026-03
Pfizer USD 16.17B 332M 2026-03
Quest Diagnostics USD 1.59B 179M 2026-03
Revvity USD 691.38M 53.29M 2026-03
Thermo Fisher Scientific USD 9.2B 304M 2026-03
United Therapeutics USD 312M 38.2M 2026-03
UnitedHealth USD 26.59B 3.57B 2026-03
Veradigm USD 175.72M 58.76M 2022-12
Waters USD 1.76B 930.16M 2026-03
West Pharmaceutical Services USD 685.6M 111.2M 2026-03